Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading ...

Mabtech, Sai Life Sciences partner to advance immunology research with EYRA platform at Sai Boston site: Boston Friday, January 30, 2026, 18:00 Hrs [IST] Mabtech, a global life sc ...

Biotech is our opening topic this morning as we deep dive into a double announcement from EQT. The firm is acquiring a Swedish biotech company as part of the launch of a new Healthcare Growth Strategy ...

Mabtech, a holding company for China mAB biotechs, has in-licensed four monoclonal antibodies to San Diego-based Sorrento Therapeutics ($SRNE) with all of the ...

The new EQT Healthcare Growth Strategy builds on EQT's 30-year healthcare track record and will focus on scaling innovative, fast-growing healthcare companies to help deliver positive outcomes across ...